The pandemic year of 2020 presented FDA with many enormous challenges, including how to use emergency authorizations to approve diagnostic tests, personal protective equipment, and therapies, how to conduct remote...more
3/11/2021
/ 21st Century Cures Act ,
Artificial Intelligence ,
Center for Drug Evaluation and Research (CDER) ,
Compliance ,
Coronavirus/COVID-19 ,
Cybersecurity ,
Diagnostic Tests ,
Digital Health ,
Emergency Use Authorization (EUA) ,
Food and Drug Administration (FDA) ,
Machine Learning ,
Maintenance ,
Medical Devices ,
Personal Protective Equipment ,
Popular ,
Technology ,
Third-Party Service Provider
Recognizing the impact of the COVID-19 pandemic on the conduct of clinical trials for drugs and medical devices, on March 18, the Food and Drug Administration (FDA) issued a guidance without prior public comment that is...more